3. QUALITY VARIATIONS

20/04/2020 MaP 0

QUESTIONS AND ANSWERS ON REGULATORY EXPECTATIONS FOR MEDICINAL PRODUCTS FOR HUMAN USE DURING THE COVID-19 PANDEMIC 3.1. Can quality requirements be waived/adapted for medicines intended […]